High-Sensitivity Cardiac Troponin I Following Gender-Affirming Hormone Therapy in Transgender Adults
Ada S. Cheung, Ingrid Bretherton, Shalem Y. Leemaqz, Sathya Perera Wedithanthrige, Leah Singh, Cherie Chiang
TL;DR
The study investigates changes in a heart-related protein in transgender individuals undergoing hormone therapy compared to cisgender individuals.
Contribution
It provides new insights into cardiac biomarker levels in transgender adults during hormone therapy.
Findings
Transgender individuals showed changes in troponin I levels over 12 months.
Levels were compared with those of cisgender men and women.
Findings suggest potential cardiac implications of hormone therapy.
Abstract
This case-control study examines high-sensitivity cardiac troponin I levels in transgender men and women over 12 months of gender affirming hormone theraoy compared with cisgender men and women
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHormonal and reproductive studies · Acute Myocardial Infarction Research